\-\ Texto\\:\\ \ \(0\)\
\-\ vss\\:\\ afebrile\ \(0\)\
\-\ pe\\:\\ cn\\ ii\\-iv\\,\\ vi\\-x\\ grossly\\ normal\\.\\ 4\\/5\\ strength\\ throughout\\ right\\ side\\.\\ sensory\\ loss\\ on\\ right\\ side\\ of\\ face\\.\\ decreased\\ sensation\\ througout\\ right\\ side\\ body\\.\ \(0\)\
\-\ reflexes\\ 2\\+\\,\\ symmetric\\ throughout\\.\\ toes\\ downgoing\\.\\ negative\\ hoffman\\'s\\.\\ heel\\ to\\ shin\\ and\ \(0\)\
\-\ 1\\.\\ tumor\\ resection\ \(1\)\
\-\ 2\\.\\ there\\ was\\ residual\\ tumor\\ present\\ on\\ post\\-operative\\ imaging\\.\\ decision\\ was\\ made\\ to\\ use\\ adjunct\\ therapy\\ with\\ chemo\\ and\\ radiation\\ vs\\.\\ additional\\ surgical\\ resection\\.\ \(0\)\
\-\ within\\ left\\ parietal\\ region\\ there\\ is\\ a\\ minimally\\ enhancing\\ area\\ of\\ t1\\ low\\ sgnal\\ measuring\\ 3\\.4x2\\.6x3cm\\.\\ on\\ t2\\ there\\ is\\ signal\\ prolongation\\.\\ there\\ is\\ mild\\ gyral\\ expansion\\ and\\ mild\\ local\\ mass\\ effect\\.\\ \ \(0\)\
\-\ the\\ mass\\ is\\ non\\-contrast\\ enhancing\\ on\\ post\\-gad\\ t1\\ imaging\\.\ \(0\)\
\-\ low\\ grade\\ glial\\ neoplasm\ \(0\)\
\-\ 1\\.\\ primary\\ glial\\ neoplasm\ \(0\)\
\-\ 2\\.\\ oligodendrocytoma\ \(0\)\
\-\ 3\\.\\ astrocytoma\ \(0\)\
\-\ 4\\.\\ infection\\-abscess\ \(0\)\
\-\ 22yo\\ male\\ with\\ 3\\.5wk\\ history\\ of\\ seizures\\ resulting\\ in\\ right\\ hemiparesis\\ and\\ right\\ sided\\ anesthesia\\.\\ patient\\ has\\ left\\ sided\\ headache\\ and\\ right\\ eye\\ diploplia\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ glial\\:\\ 0\\.24905860914597233\ \(0\)\
\-\ side\\:\\ 0\\.19847084337389165\ \(0\)\
\-\ right\\:\\ 0\\.19049970773287817\ \(0\)\
\-\ througout\\:\\ 0\\.15314855941335748\ \(0\)\
\-\ sgnal\\:\\ 0\\.15314855941335748\ \(0\)\
\-\ oligodendrocytoma\\:\\ 0\\.15314855941335748\ \(0\)\
\-\ diploplia\\:\\ 0\\.15314855941335748\ \(0\)\
\-\ there\\:\\ 0\\.1524178639953238\ \(0\)\
\-\ downgoing\\:\\ 0\\.14634162452916036\ \(0\)\
\-\ throughout\\:\\ 0\\.1408599735725872\ \(0\)\
\-\ 22yo\\:\\ 0\\.13211721594790043\ \(0\)\
\-\ neoplasm\\:\\ 0\\.13074765585565218\ \(0\)\
\-\ hoffman\\:\\ 0\\.12987549532529924\ \(0\)\
\-\ sided\\:\\ 0\\.1232014365188339\ \(0\)\
\-\ resection\\:\\ 0\\.12277280175101873\ \(0\)\
\-\ gyral\\:\\ 0\\.1217248061002397\ \(0\)\
\-\ adjunct\\:\\ 0\\.1204806839038713\ \(0\)\
\-\ chemo\\:\\ 0\\.1204806839038713\ \(0\)\
\-\ enhancing\\:\\ 0\\.11998170562839344\ \(0\)\
\-\ t1\\:\\ 0\\.11933475046545265\ \(0\)\
\-\ prolongation\\:\\ 0\\.11722119912639871\ \(0\)\
\-\ on\\:\\ 0\\.11569029951936485\ \(0\)\
\-\ shin\\:\\ 0\\.11143202839707297\ \(0\)\
\-\ vss\\:\\ 0\\.11008827405621056\ \(0\)\
\-\ anesthesia\\:\\ 0\\.11008827405621056\ \(0\)\
\-\ low\\:\\ 0\\.10990057521587733\ \(0\)\
\-\ decision\\:\\ 0\\.10884415185984217\ \(0\)\
\-\ mild\\:\\ 0\\.10857254030311803\ \(0\)\
\-\ hemiparesis\\:\\ 0\\.10558466708236959\ \(0\)\
\-\ is\\:\\ 0\\.1049032247982737\ \(0\)\
\-\ heel\\:\\ 0\\.10285630464521095\ \(0\)\
\-\ toes\\:\\ 0\\.10164218775990981\ \(0\)\
\-\ imaging\\:\\ 0\\.10065515262813869\ \(0\)\
\-\ tumor\\:\\ 0\\.10018095990789787\ \(0\)\
\-\ and\\:\\ 0\\.09894298568383945\ \(0\)\
\-\ cn\\:\\ 0\\.09346149322378301\ \(0\)\
\-\ grossly\\:\\ 0\\.09186142906349998\ \(0\)\
\-\ minimally\\:\\ 0\\.09080523383406669\ \(0\)\
\-\ sensory\\:\\ 0\\.09020200844631042\ \(0\)\
\-\ expansion\\:\\ 0\\.08730660018242269\ \(0\)\
\-\ residual\\:\\ 0\\.08714120015414333\ \(0\)\
\-\ face\\:\\ 0\\.08633779484636521\ \(0\)\
\-\ reflexes\\:\\ 0\\.08372751941712175\ \(0\)\
\-\ afebrile\\:\\ 0\\.08268607131700118\ \(0\)\
\-\ local\\:\\ 0\\.08243549999261952\ \(0\)\
\-\ sensation\\:\\ 0\\.08206651883032273\ \(0\)\
\-\ symmetric\\:\\ 0\\.08206651883032273\ \(0\)\
\-\ strength\\:\\ 0\\.08022489701947084\ \(0\)\
\-\ resulting\\:\\ 0\\.0796884946139858\ \(0\)\
\-\ pe\\:\\ 0\\.07916870179003757\ \(0\)\
\-\ seizures\\:\\ 0\\.07817504096604473\ \(0\)\
\-\ parietal\\:\\ 0\\.07732840945588985\ \(0\)\
\-\ eye\\:\\ 0\\.07661009808859856\ \(0\)\
\-\ additional\\:\\ 0\\.07423704980483962\ \(0\)\
\-\ measuring\\:\\ 0\\.07408512146411458\ \(0\)\
\-\ made\\:\\ 0\\.07385977624075751\ \(0\)\
\-\ use\\:\\ 0\\.07327323738490722\ \(0\)\
\-\ mass\\:\\ 0\\.07315909689729001\ \(0\)\
\-\ vs\\:\\ 0\\.0730584630218441\ \(0\)\
\-\ astrocytoma\\:\\ 0\\.07229366146934046\ \(0\)\
\-\ grade\\:\\ 0\\.06886313325419642\ \(0\)\
\-\ effect\\:\\ 0\\.06717765953059776\ \(0\)\
\-\ was\\:\\ 0\\.06674987298631051\ \(0\)\
\-\ headache\\:\\ 0\\.06601606891921144\ \(0\)\
\-\ left\\:\\ 0\\.06533483685912617\ \(0\)\
\-\ radiation\\:\\ 0\\.0634616278980578\ \(0\)\
\-\ body\\:\\ 0\\.06302555228761297\ \(0\)\
\-\ area\\:\\ 0\\.06203773991066522\ \(0\)\
\-\ decreased\\:\\ 0\\.059318604166276934\ \(0\)\
\-\ negative\\:\\ 0\\.05928725407859869\ \(0\)\
\-\ primary\\:\\ 0\\.05888494252766358\ \(0\)\
\-\ loss\\:\\ 0\\.05834334823499535\ \(0\)\
\-\ region\\:\\ 0\\.057282098672519814\ \(0\)\
\-\ of\\:\\ 0\\.05622216762144986\ \(0\)\
\-\ t2\\:\\ 0\\.05509605958379332\ \(0\)\
\-\ therapy\\:\\ 0\\.05502301537687128\ \(0\)\
\-\ signal\\:\\ 0\\.05428627015155901\ \(0\)\
\-\ present\\:\\ 0\\.04913996382577176\ \(0\)\
\-\ to\\:\\ 0\\.04788196004627777\ \(0\)\
\-\ surgical\\:\\ 0\\.04654475469743374\ \(0\)\
\-\ within\\:\\ 0\\.04410625512946513\ \(0\)\
\-\ has\\:\\ 0\\.04374251206546909\ \(0\)\
\-\ male\\:\\ 0\\.042638116115322526\ \(0\)\
\-\ normal\\:\\ 0\\.03910007366761303\ \(0\)\
\-\ with\\:\\ 0\\.03750384023547112\ \(0\)\
\-\ history\\:\\ 0\\.03658764879479641\ \(0\)\
\-\ patient\\:\\ 0\\.03114744048028402\ \(0\)\
\-\ in\\:\\ 0\\.023823142569048467\ \(0\)\
\-\ the\\:\\ 0\\.01910852217196948\ \(0\)\
